NIRAF Detection for Thyroid Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to locate parathyroid glands during thyroid surgery using near infrared autofluorescence (NIRAF) with a device called PTeye. The researchers aim to determine if this technology makes the surgery safer and more effective than relying solely on the surgeon's eyesight. It targets individuals requiring a total thyroidectomy who do not have parathyroid diseases. Those advised to undergo this type of surgery might be suitable candidates for the trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative surgical advancements that could improve patient safety and outcomes.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this device is safe for identifying parathyroid glands during thyroid surgery?
Research has shown that near-infrared autofluorescence (NIRAF) technology can enhance the safety of thyroid surgery. In one study, NIRAF helped surgeons avoid accidentally removing parathyroid glands in 21% of cases, which is crucial because removing these glands can lead to complications. Another study found that NIRAF outperformed the naked eye in identifying all four parathyroid glands during surgery, reducing the risk of postoperative issues like low calcium levels.
The NIRAF tool used in these trials has already received FDA approval, indicating it has been evaluated for safety in other contexts. While testing in new scenarios remains important, these earlier findings suggest the technology is generally safe and well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about the NIRAF Detection Technology for thyroid surgery because it offers a potentially more precise method for identifying parathyroid glands during surgery. Unlike traditional methods that rely solely on the surgeon's visual identification, this technology uses near-infrared autofluorescence (NIRAF) to highlight the parathyroid glands. This could significantly reduce the risk of accidental damage to these glands, which is a common complication during thyroid surgery. By integrating this innovative tool, surgeons hope to improve surgical outcomes and reduce postoperative complications for patients undergoing total thyroidectomy.
What evidence suggests that NIRAF detection technology is effective for identifying parathyroid glands during thyroid surgery?
Research has shown that near-infrared autofluorescence (NIRAF) technology can significantly enhance the identification of parathyroid glands during thyroid surgery. In this trial, one group of participants will undergo parathyroid gland identification with NIRAF detection technology, while another group will rely on the surgeon's visual identification without NIRAF. Surgeons using NIRAF identified 17.9% more parathyroid glands than those using only visual methods. This technology enhances the visibility of the glands, helping to protect their function. In some cases, NIRAF prevented the accidental removal of the parathyroid glands in 21% of surgeries. Overall, NIRAF serves as a valuable tool for making thyroid surgeries safer and more effective.12678
Who Is on the Research Team?
Tracy S Wang, MD, MPH
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
This trial is for patients who are set to undergo a complete thyroid removal surgery, with or without lymph node dissection. It's not for those who only need part of their thyroid removed, have parathyroid disease, or find an enlarged parathyroid during surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo total thyroidectomy with or without lymph node dissection, with or without NIRAF detection technology
Postoperative Monitoring
Participants are monitored for postoperative hypocalcemia and other complications
Follow-up
Participants are monitored for safety and effectiveness after treatment, including hypocalcemia and parathyroid function
What Are the Treatments Tested in This Trial?
Interventions
- NIRAF Detection Technology
Trial Overview
The study tests NIRAF Detection Technology using the 'Parathyroid Eye (PTeye)' device to see if it helps surgeons better identify parathyroid glands during total thyroidectomy compared to surgeries where this technology isn't used.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Parathyroid gland identification will be performed with PTeye using NIRAF detection technology as an adjunctive tool in patients who undergo total thyroidectomy (TTx) with or without lymph node dissection (LND).
Parathyroid gland identification will be performed by the surgeon using only visual identification and without using PTeye - NIRAF detection technology in patients who undergo total thyroidectomy (TTx) with or without lymph node dissection (LND).
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor
Vanderbilt University
Collaborator
National Cancer Institute (NCI)
Collaborator
Citations
Near-Infrared Autofluorescence for Parathyroid Detection ...
During thyroidectomy, surgeons, on average, identified 17.9% more PGs (3.3 per patient) when using NIRAF than the control (2.8 per patient).
Near-Infrared Autofluorescence for Parathyroid Detection ...
After using NIRAF, the senior surgeons rated 23.9% as medium and low, and the juniors only rated 13.6% of PGs with medium and low confidence ( ...
Evaluation of the effectiveness of near-infrared ...
Conclusions. Compared to traditional visual recognition, the NIRAF-ICGT integrated technology can help surgeons better identify and protect parathyroid function ...
NCT05579782 | Assessing Benefits of NIRAF Detection for ...
It compares risk-benefits and outcomes in patients undergoing total thyroidectomy where NIRAF detection with PTeye for parathyroid identification is either used ...
Parathyroid glands viability assessment and identification ...
Sehnem et al. demonstrated that NIRAF prevented inadvertent parathyroidectomy in 21% of cases, highlighting the importance of reliable PTG ...
The impact of using near-infrared autofluorescence ...
NIRAF is superior to the naked eye in identifying all four PGs during TT. The reduced risk of postoperative hypoparathyroidism and hypocalcemia reflected this ...
Study Details | NCT04299425 | Evaluating Impact of NIRAF ...
It compares risk-benefits and outcomes in PTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used. Detailed ...
Does the use of probe-based near infrared autofluorescence ...
The results of this first randomized clinical trial with probe-based NIRAF detection suggest that this technology could improve parathyroid gland identification ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.